Perkins Capital Management Inc 9 Meters Biopharma, Inc. Transaction History

Perkins Capital Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$1.04 - $1.5 $364,000 - $525,000	-350,000 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$0.84 - $2.16 $42,000 - $108,000	50,000 Added 16.67%	350,000 $410,000
Q4 2020 Feb 09, 2021	BUY	$0.65 - $1.11 $195,000 - $333,000	300,000 New	300,000 $258,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.